Androgen Excess and PCOS Society
@aepcossociety.bsky.social
We are dedicated to improving women’s health by promoting basic and clinical scientific research in all aspects related to #PCOS and androgen excess disorders.
Reposted by Androgen Excess and PCOS Society
Large retrospective cohort study shows that exposure to GLP-1 RAs before pregnancy results in higher weight gain & more pregnancy complications than no GLP-1 RAs exposure prior to pregnancy - GLP-1 RAs will not be a good solution for women with PCOS desiring fertility jamanetwork.com/journals/jam...
Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation
This cohort study examines gestational weight gain and pregnancy outcomes after glucagon-like peptide-1 (GLP-1) receptor agonist discontinuation.
jamanetwork.com
November 27, 2025 at 4:47 PM
Large retrospective cohort study shows that exposure to GLP-1 RAs before pregnancy results in higher weight gain & more pregnancy complications than no GLP-1 RAs exposure prior to pregnancy - GLP-1 RAs will not be a good solution for women with PCOS desiring fertility jamanetwork.com/journals/jam...
🗓️ Meet the Professor session - TODAY, Thu, Nov. 27th at 7am EST (1pm CET).
🎙️ Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
🎙️ Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
November 27, 2025 at 8:26 AM
🗓️ Meet the Professor session - TODAY, Thu, Nov. 27th at 7am EST (1pm CET).
🎙️ Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
🎙️ Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
May 9th, 2026 📍 Prague 🇨🇿
#ECE2026
🔗 www.ese-hormones.org/ece2026
“Novel therapies for the treatment of PCOS”
Sessions will highlight advances in targeted pharmacological treatments, lifestyle and metabolic interventions, and novel approaches involving neuroendocrine, immune, and gut–brain pathways.
#ECE2026
🔗 www.ese-hormones.org/ece2026
“Novel therapies for the treatment of PCOS”
Sessions will highlight advances in targeted pharmacological treatments, lifestyle and metabolic interventions, and novel approaches involving neuroendocrine, immune, and gut–brain pathways.
November 24, 2025 at 10:14 AM
May 9th, 2026 📍 Prague 🇨🇿
#ECE2026
🔗 www.ese-hormones.org/ece2026
“Novel therapies for the treatment of PCOS”
Sessions will highlight advances in targeted pharmacological treatments, lifestyle and metabolic interventions, and novel approaches involving neuroendocrine, immune, and gut–brain pathways.
#ECE2026
🔗 www.ese-hormones.org/ece2026
“Novel therapies for the treatment of PCOS”
Sessions will highlight advances in targeted pharmacological treatments, lifestyle and metabolic interventions, and novel approaches involving neuroendocrine, immune, and gut–brain pathways.
🗓️ Meet the Professor session - Thursday, Nov. 27 @ 7am EST (1pm CET).
🎤 Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
🎤 Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
November 20, 2025 at 8:08 PM
🗓️ Meet the Professor session - Thursday, Nov. 27 @ 7am EST (1pm CET).
🎤 Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
🎤 Learn more about Dr Paolo Giacobini's work and insights on neuroendocrinology.
🔗 EC-SIG members, check your email for the Zoom link 👍
💵 Spending on AI-powered wearables is expected to exceed $300 billion in 2033.
❤️ Healthcare use cases are leading adoption.
⌚️ Wearables transform the way people approach health and wellness.
tech.yahoo.com/wearables/ar...
❤️ Healthcare use cases are leading adoption.
⌚️ Wearables transform the way people approach health and wellness.
tech.yahoo.com/wearables/ar...
Why the AI wearable market is set to grow by 10x - and it's not just new gadgets
Spending on AI-powered wearables is expected to reach $304.8 billion by 2033, as consumers adopt new health and wellness routines.
tech.yahoo.com
November 1, 2025 at 7:34 AM
💵 Spending on AI-powered wearables is expected to exceed $300 billion in 2033.
❤️ Healthcare use cases are leading adoption.
⌚️ Wearables transform the way people approach health and wellness.
tech.yahoo.com/wearables/ar...
❤️ Healthcare use cases are leading adoption.
⌚️ Wearables transform the way people approach health and wellness.
tech.yahoo.com/wearables/ar...
ORAL PRESENTATIONS
Chairs: Rebecca Campbell & Mahua Ghosh
Development of an artificial intelligence foundation model for the interpretation of pelvic ultrasonography in PCOS 👉 Eeshan Rehaani 🇺🇸
Chairs: Rebecca Campbell & Mahua Ghosh
Development of an artificial intelligence foundation model for the interpretation of pelvic ultrasonography in PCOS 👉 Eeshan Rehaani 🇺🇸
October 25, 2025 at 8:47 PM
ORAL PRESENTATIONS
Chairs: Rebecca Campbell & Mahua Ghosh
Development of an artificial intelligence foundation model for the interpretation of pelvic ultrasonography in PCOS 👉 Eeshan Rehaani 🇺🇸
Chairs: Rebecca Campbell & Mahua Ghosh
Development of an artificial intelligence foundation model for the interpretation of pelvic ultrasonography in PCOS 👉 Eeshan Rehaani 🇺🇸
ORAL PRESENTATIONS
Chairs: Rebecca Campbell & Mahua Ghosh
Predictors of disordered eating in women with PCOS: a meta-analysis 👉 Riley Huddleston 🇺🇸
Chairs: Rebecca Campbell & Mahua Ghosh
Predictors of disordered eating in women with PCOS: a meta-analysis 👉 Riley Huddleston 🇺🇸
October 25, 2025 at 8:30 PM
ORAL PRESENTATIONS
Chairs: Rebecca Campbell & Mahua Ghosh
Predictors of disordered eating in women with PCOS: a meta-analysis 👉 Riley Huddleston 🇺🇸
Chairs: Rebecca Campbell & Mahua Ghosh
Predictors of disordered eating in women with PCOS: a meta-analysis 👉 Riley Huddleston 🇺🇸
ORAL PRESENTATIONS
Chairs: Rebecca Campbell & Mahua Ghosh
Health-related quality of function in PCOS: assessing the impact of combined oral contraceptive pills and metformin therapy 👉 Joshua Ewy 🇺🇸
Chairs: Rebecca Campbell & Mahua Ghosh
Health-related quality of function in PCOS: assessing the impact of combined oral contraceptive pills and metformin therapy 👉 Joshua Ewy 🇺🇸
October 25, 2025 at 8:16 PM
ORAL PRESENTATIONS
Chairs: Rebecca Campbell & Mahua Ghosh
Health-related quality of function in PCOS: assessing the impact of combined oral contraceptive pills and metformin therapy 👉 Joshua Ewy 🇺🇸
Chairs: Rebecca Campbell & Mahua Ghosh
Health-related quality of function in PCOS: assessing the impact of combined oral contraceptive pills and metformin therapy 👉 Joshua Ewy 🇺🇸
SESSION 7: PCOS and Reproduction
Chairs: Marcelle Cedars & Richard Legro
Long-Term Effects of Prenatal Metformin Exposure and Maternal PCOS on Childhood Immunity and Mental Health 🎤 Prof Eszter Vanky 🇳🇴
Chairs: Marcelle Cedars & Richard Legro
Long-Term Effects of Prenatal Metformin Exposure and Maternal PCOS on Childhood Immunity and Mental Health 🎤 Prof Eszter Vanky 🇳🇴
October 25, 2025 at 7:49 PM
SESSION 7: PCOS and Reproduction
Chairs: Marcelle Cedars & Richard Legro
Long-Term Effects of Prenatal Metformin Exposure and Maternal PCOS on Childhood Immunity and Mental Health 🎤 Prof Eszter Vanky 🇳🇴
Chairs: Marcelle Cedars & Richard Legro
Long-Term Effects of Prenatal Metformin Exposure and Maternal PCOS on Childhood Immunity and Mental Health 🎤 Prof Eszter Vanky 🇳🇴
SESSION 7: PCOS and Reproduction
Chairs: Richard Legro & Marcelle Cedars
Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with #PCOS - The MYPP trial 🎤 by Prof Joop Laven 🇳🇱
Chairs: Richard Legro & Marcelle Cedars
Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with #PCOS - The MYPP trial 🎤 by Prof Joop Laven 🇳🇱
October 25, 2025 at 7:24 PM
SESSION 7: PCOS and Reproduction
Chairs: Richard Legro & Marcelle Cedars
Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with #PCOS - The MYPP trial 🎤 by Prof Joop Laven 🇳🇱
Chairs: Richard Legro & Marcelle Cedars
Myo-inositol Supplementation to Prevent Pregnancy Complications in Women with #PCOS - The MYPP trial 🎤 by Prof Joop Laven 🇳🇱
Early-career networking session (chaired by Dr Tina Gorsek & Dr Jamie Benham)
23rd Annual Meeting of the AEPCOS Society in San Antonio, TX 🇺🇸
23rd Annual Meeting of the AEPCOS Society in San Antonio, TX 🇺🇸
October 25, 2025 at 6:32 PM
Early-career networking session (chaired by Dr Tina Gorsek & Dr Jamie Benham)
23rd Annual Meeting of the AEPCOS Society in San Antonio, TX 🇺🇸
23rd Annual Meeting of the AEPCOS Society in San Antonio, TX 🇺🇸
SESSION 6: Award Lecture
🏆 Walter Futterweit Award in Clinical Research
Prof Jeff Chang 🇺🇸
Chairs: Kathy Hoeger & Zi-Jiang Chen
🏆 Walter Futterweit Award in Clinical Research
Prof Jeff Chang 🇺🇸
Chairs: Kathy Hoeger & Zi-Jiang Chen
October 25, 2025 at 4:53 PM
SESSION 6: Award Lecture
🏆 Walter Futterweit Award in Clinical Research
Prof Jeff Chang 🇺🇸
Chairs: Kathy Hoeger & Zi-Jiang Chen
🏆 Walter Futterweit Award in Clinical Research
Prof Jeff Chang 🇺🇸
Chairs: Kathy Hoeger & Zi-Jiang Chen
Pathophysiology of androgen-associated endothelial cell dysfunction in phenotype A PCOS revealed by iPSCs modeling 🎤 Chu-Chun Huang 🇹🇼
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
October 25, 2025 at 4:28 PM
Pathophysiology of androgen-associated endothelial cell dysfunction in phenotype A PCOS revealed by iPSCs modeling 🎤 Chu-Chun Huang 🇹🇼
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
Elevated prenatal anti-Müllerian hormone lowers gestational β-cell mass but induces few other metabolic changes in mice with reduced insulin gene dosage 🎤 Nicole Templeman 🇨🇦
Chairs: Vasantha Padmanabhan & Han Zhao
Elevated prenatal anti-Müllerian hormone lowers gestational β-cell mass but induces few other metabolic changes in mice with reduced insulin gene dosage 🎤 Nicole Templeman 🇨🇦
October 25, 2025 at 4:13 PM
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
Elevated prenatal anti-Müllerian hormone lowers gestational β-cell mass but induces few other metabolic changes in mice with reduced insulin gene dosage 🎤 Nicole Templeman 🇨🇦
Chairs: Vasantha Padmanabhan & Han Zhao
Elevated prenatal anti-Müllerian hormone lowers gestational β-cell mass but induces few other metabolic changes in mice with reduced insulin gene dosage 🎤 Nicole Templeman 🇨🇦
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
The differences of spontaneous conception versus assisted reproductive technology on pregnancy outcomes in women with PCOS and their offspring traits 🎤 Atta Tsang 🇭🇰
Chairs: Vasantha Padmanabhan & Han Zhao
The differences of spontaneous conception versus assisted reproductive technology on pregnancy outcomes in women with PCOS and their offspring traits 🎤 Atta Tsang 🇭🇰
October 25, 2025 at 3:55 PM
ORAL PRESENTATIONS
Chairs: Vasantha Padmanabhan & Han Zhao
The differences of spontaneous conception versus assisted reproductive technology on pregnancy outcomes in women with PCOS and their offspring traits 🎤 Atta Tsang 🇭🇰
Chairs: Vasantha Padmanabhan & Han Zhao
The differences of spontaneous conception versus assisted reproductive technology on pregnancy outcomes in women with PCOS and their offspring traits 🎤 Atta Tsang 🇭🇰
SESSION 5: Pregnancy & Child Outcomes
Chairs: Sharon Oberfield and Tania Burgert
Dr. Nicolas Crisosto 🇨🇱
Child outcomes in children of women with #PCOS
Chairs: Sharon Oberfield and Tania Burgert
Dr. Nicolas Crisosto 🇨🇱
Child outcomes in children of women with #PCOS
October 25, 2025 at 2:50 PM
SESSION 5: Pregnancy & Child Outcomes
Chairs: Sharon Oberfield and Tania Burgert
Dr. Nicolas Crisosto 🇨🇱
Child outcomes in children of women with #PCOS
Chairs: Sharon Oberfield and Tania Burgert
Dr. Nicolas Crisosto 🇨🇱
Child outcomes in children of women with #PCOS
SESSION 5: Pregnancy & Child Outcomes
Chairs: Sharon Oberfield and Tania Burgert
Dr. Jessica L. Chan 🇺🇸
Correlation between PCOS phenotype and pregnancy and neonatal outcome
Chairs: Sharon Oberfield and Tania Burgert
Dr. Jessica L. Chan 🇺🇸
Correlation between PCOS phenotype and pregnancy and neonatal outcome
October 25, 2025 at 2:38 PM
SESSION 5: Pregnancy & Child Outcomes
Chairs: Sharon Oberfield and Tania Burgert
Dr. Jessica L. Chan 🇺🇸
Correlation between PCOS phenotype and pregnancy and neonatal outcome
Chairs: Sharon Oberfield and Tania Burgert
Dr. Jessica L. Chan 🇺🇸
Correlation between PCOS phenotype and pregnancy and neonatal outcome
AE-PCOS Society Update, Award Presentations, Poster Awards 👉 Prof. Anuja Dokras
San Antonio, TX 🇺🇸
AE-PCOS Award - Victoria Bailey, Michigan State University
@veritypcos.bsky.social Award - Tess Cherlin, University of Pennsylvania
San Antonio, TX 🇺🇸
AE-PCOS Award - Victoria Bailey, Michigan State University
@veritypcos.bsky.social Award - Tess Cherlin, University of Pennsylvania
October 25, 2025 at 2:28 PM
AE-PCOS Society Update, Award Presentations, Poster Awards 👉 Prof. Anuja Dokras
San Antonio, TX 🇺🇸
AE-PCOS Award - Victoria Bailey, Michigan State University
@veritypcos.bsky.social Award - Tess Cherlin, University of Pennsylvania
San Antonio, TX 🇺🇸
AE-PCOS Award - Victoria Bailey, Michigan State University
@veritypcos.bsky.social Award - Tess Cherlin, University of Pennsylvania
Early and Mid-career Leadership Session #AEPCOS2025
Tina Gorsek
Jamie Benham
Snigdha Alur-Gupta
@elisabetsv.bsky.social
Tina Gorsek
Jamie Benham
Snigdha Alur-Gupta
@elisabetsv.bsky.social
October 25, 2025 at 1:22 PM
Early and Mid-career Leadership Session #AEPCOS2025
Tina Gorsek
Jamie Benham
Snigdha Alur-Gupta
@elisabetsv.bsky.social
Tina Gorsek
Jamie Benham
Snigdha Alur-Gupta
@elisabetsv.bsky.social
Lower prevalence of menopausal symptoms and postmenopausal status in women with PCOS at age 46 – a population-based cohort study (Recorded session) 👉 Johanna Lavi 🇫🇮
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
October 24, 2025 at 8:11 PM
Lower prevalence of menopausal symptoms and postmenopausal status in women with PCOS at age 46 – a population-based cohort study (Recorded session) 👉 Johanna Lavi 🇫🇮
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
Discovery of small molecule inhibitors of AKR1C3 with in vitro and in vivo efficacy in modulating androgen excess 👉 Alpha Lee 🇺🇸
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
October 24, 2025 at 8:06 PM
Discovery of small molecule inhibitors of AKR1C3 with in vitro and in vivo efficacy in modulating androgen excess 👉 Alpha Lee 🇺🇸
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
Improved fertility over time in women with PCOS 👉 Terhi Piltonen 🇫🇮
Co-chaired by Rob Norman & Heidi Vanden Brink
Improved fertility over time in women with PCOS 👉 Terhi Piltonen 🇫🇮
October 24, 2025 at 7:41 PM
ORAL PRESENTATIONS
Co-chaired by Rob Norman & Heidi Vanden Brink
Improved fertility over time in women with PCOS 👉 Terhi Piltonen 🇫🇮
Co-chaired by Rob Norman & Heidi Vanden Brink
Improved fertility over time in women with PCOS 👉 Terhi Piltonen 🇫🇮
SESSION 4: EARLY INVESTIGATOR AWARDS
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: A transcriptomic atlas of skeletal muscle in women with PCOS 👉 Tina Gorsek Sparovec 🇸🇪
👏👏👏
@elisabetsv.bsky.social
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: A transcriptomic atlas of skeletal muscle in women with PCOS 👉 Tina Gorsek Sparovec 🇸🇪
👏👏👏
@elisabetsv.bsky.social
October 24, 2025 at 7:18 PM
SESSION 4: EARLY INVESTIGATOR AWARDS
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: A transcriptomic atlas of skeletal muscle in women with PCOS 👉 Tina Gorsek Sparovec 🇸🇪
👏👏👏
@elisabetsv.bsky.social
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: A transcriptomic atlas of skeletal muscle in women with PCOS 👉 Tina Gorsek Sparovec 🇸🇪
👏👏👏
@elisabetsv.bsky.social
SESSION 4: EARLY INVESTIGATOR AWARDS
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: Unbiased clustering identifies distinct ovarian phenotypes that align with reproductive and metabolic outcomes 👉 Abbey Kalay 🇺🇸
👏👏👏
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: Unbiased clustering identifies distinct ovarian phenotypes that align with reproductive and metabolic outcomes 👉 Abbey Kalay 🇺🇸
👏👏👏
October 24, 2025 at 7:00 PM
SESSION 4: EARLY INVESTIGATOR AWARDS
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: Unbiased clustering identifies distinct ovarian phenotypes that align with reproductive and metabolic outcomes 👉 Abbey Kalay 🇺🇸
👏👏👏
Chairs: Ricardo Azziz and Marla Lujan
Azziz-Baumgartner Family Early Career Investigator Award: Unbiased clustering identifies distinct ovarian phenotypes that align with reproductive and metabolic outcomes 👉 Abbey Kalay 🇺🇸
👏👏👏
Apple Women's Health study – fertility outcomes 👉 by @smahalingaiahmd.bsky.social 🇺🇸
SESSION 3, chaired by Terhi Piltonen & Miyuki Harada: Fertility & Infertility
SESSION 3, chaired by Terhi Piltonen & Miyuki Harada: Fertility & Infertility
October 24, 2025 at 4:39 PM
Apple Women's Health study – fertility outcomes 👉 by @smahalingaiahmd.bsky.social 🇺🇸
SESSION 3, chaired by Terhi Piltonen & Miyuki Harada: Fertility & Infertility
SESSION 3, chaired by Terhi Piltonen & Miyuki Harada: Fertility & Infertility